|
Mechanism5-HT3A receptor antagonists [+1] |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhaseWithdrawn |
First Approval Ctry. / Loc.US |
First Approval Date28 Nov 1947 |
100 Clinical Results associated with 5-HT3A receptor x CHRNA2
100 Translational Medicine associated with 5-HT3A receptor x CHRNA2
0 Patents (Medical) associated with 5-HT3A receptor x CHRNA2